Matrix metalloproteinase 2 as a pharmacological target in heart failure
PR Gonçalves, LD Nascimento, RF Gerlach… - Pharmaceuticals, 2022 - mdpi.com
Heart failure (HF) is an acute or chronic clinical syndrome that results in a decrease in
cardiac output and an increase in intracardiac pressure at rest or upon exertion. The …
cardiac output and an increase in intracardiac pressure at rest or upon exertion. The …
RUNX1: an emerging therapeutic target for cardiovascular disease
A Riddell, M McBride, T Braun, SA Nicklin… - Cardiovascular …, 2020 - academic.oup.com
Abstract Runt-related transcription factor-1 (RUNX1), also known as acute myeloid
leukaemia 1 protein (AML1), is a member of the core-binding factor family of transcription …
leukaemia 1 protein (AML1), is a member of the core-binding factor family of transcription …
[HTML][HTML] Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement
H Amirfakhryan - Hellenic Journal of Cardiology, 2021 - Elsevier
Since the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has emerged
from China, the infection (novel corona virus disease-2019, COVID-19) has affected many …
from China, the infection (novel corona virus disease-2019, COVID-19) has affected many …
Decoding empagliflozin's molecular mechanism of action in heart failure with preserved ejection fraction using artificial intelligence
A Bayes-Genis, O Iborra-Egea, G Spitaleri… - Scientific reports, 2021 - nature.com
The use of sodium-glucose co-transporter 2 inhibitors to treat heart failure with preserved
ejection fraction (HFpEF) is under investigation in ongoing clinical trials, but the exact …
ejection fraction (HFpEF) is under investigation in ongoing clinical trials, but the exact …
Angiotensin Ⅱ activates MCP-1 and induces cardiac hypertrophy and dysfunction via toll-like receptor 4
S Matsuda, S Umemoto, K Yoshimura, S Itoh… - … of atherosclerosis and …, 2015 - jstage.jst.go.jp
Aim: Angiotensin Ⅱ (Ang Ⅱ) produces reactive oxygen species (ROS), thus contributing to
the development of cardiac hypertrophy and subsequent heart failure, and stimulates the …
the development of cardiac hypertrophy and subsequent heart failure, and stimulates the …
Multiscale simulations of left ventricular growth and remodeling
Cardiomyocytes can adapt their size, shape, and orientation in response to altered
biomechanical or biochemical stimuli. The process by which the heart undergoes structural …
biomechanical or biochemical stimuli. The process by which the heart undergoes structural …
Left ventricular diastolic function in subjects conceived through assisted reproductive technologies
F Sciuk, T Vilsmaier, M Kramer, M Langer… - Journal of Clinical …, 2022 - mdpi.com
Subjects conceived through assisted reproductive technologies (ART) potentially suffer from
impaired left ventricular (LV) function due to premature vascular aging. This study aimed to …
impaired left ventricular (LV) function due to premature vascular aging. This study aimed to …
Intermittent electrical stimulation of the right cervical vagus nerve in salt‐sensitive hypertensive rats: effects on blood pressure, arrhythmias, and ventricular …
EM Annoni, X Xie, SW Lee, I Libbus… - Physiological …, 2015 - Wiley Online Library
Hypertension (HTN) is the single greatest risk factor for potentially fatal cardiovascular
diseases. One cause of HTN is inappropriately increased sympathetic nervous system …
diseases. One cause of HTN is inappropriately increased sympathetic nervous system …
The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats
Q Liu, L Adams, A Broyde, R Fernandez… - Cardiovascular …, 2010 - Springer
Background Activation of glucagon-like peptide-1 (GLP-1) receptors improves insulin
sensitivity and induces vasodilatation and diuresis. AC3174 is a peptide analogue with …
sensitivity and induces vasodilatation and diuresis. AC3174 is a peptide analogue with …
NR3C2 genotype is associated with response to spironolactone in diastolic heart failure patients from the Aldo‐DHF trial
L Dumeny, O Vardeny, F Edelmann… - … : The Journal of …, 2021 - Wiley Online Library
Abstract Study Objective This study aimed to determine if variants in NR3C2, which codes
the target protein of spironolactone, or CYP11B2, which is involved in aldosterone synthesis …
the target protein of spironolactone, or CYP11B2, which is involved in aldosterone synthesis …